Unlock trapped value
Discontinued and unused ANDAs generate no revenue but still carry real market value. We convert that dead weight on your books into cash.
ANDA Exchange is the dedicated marketplace for approved, discontinued, and unused Abbreviated New Drug Applications — privately connecting sellers with a vetted network of 5,000+ prospective buyers.
Selling instead? List your ANDA confidentially →
Thousands of approved ANDAs sit unused on company shelves and the FDA discontinued list. We exist to match those assets with manufacturers actively looking to enter the market — quickly, discreetly, and at fair value.
Discontinued and unused ANDAs generate no revenue but still carry real market value. We convert that dead weight on your books into cash.
We've spent years building relationships with 5,000+ generic manufacturers and marketers. Your asset reaches the right desks immediately.
Listings are anonymized. Your company's identity is never revealed to a prospect until you've approved them under a confidentiality agreement.
Tell us which ANDAs you hold. We build an anonymized listing — no company name attached.
We establish a market valuation and discreetly promote the asset to matched buyers in our network.
We manage offers, broker the negotiation, and support the buyer's due diligence on the dossier.
The deal closes between you and the buyer. We collect only a small percentage of your proceeds.
Tablet · 267 mg, 534 mg, 801 mg
View in marketplaceTablet · 24/26, 49/51, 97/103 mg
View in marketplaceCapsule · 75, 100, 125 mg
View in marketplaceDivesting an ANDA isn't a generic M&A transaction. It demands fluency in FDA dossiers, generic market dynamics, and the handful of companies who'll actually pay for a given application. That's the only thing we do.
Exclusively ANDAs — not a sideline of a broader brokerage.
We're paid when you are. No retainers, no listing fees.
Buyers we've worked with for years, not a cold database.
Your identity stays private until an NDA is in place.
Confidential valuation, buyer matching, and diligence support — handled end to end, under NDA.
New ANDA opportunities, market notes, and divestment insight — sent occasionally, never spam.
A confidential, no-obligation conversation is the first step. Tell us what you hold and we'll tell you what it's worth.
ANDA Exchange is one of four specialist firms working across the pharmaceutical lifecycle.

Pharmaceutical in-licensing for the U.S. and Canadian market.
Visit Global PharmaPartners →
Investment and financing partner — smart strategies for a complex world.
Visit Intelligentzia →Biologics and biosimilars licensing for the markets of the future.
Visit BioFutureRx →